Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genentech
Biotech
Roche culls cough candidate, pivots KRAS program in Q3 update
Roche axed the cough program as part of a wider pullback from prospects that fell short of the bar for further development.
Nick Paul Taylor
Oct 23, 2024 6:35am
Roche tosses out $120M tau prospect, returning rights to UCB
Oct 22, 2024 8:30am
Roche MAGE-A4 trial withdrawn after strategic review
Oct 18, 2024 5:30am
Biopharma layoff rate stabilizes in Q3: Fierce Biotech analysis
Oct 4, 2024 3:50pm
Relay sheds 10% of staff after earlier layoffs in July
Oct 3, 2024 4:23pm
Genentech pays $850M upfront for Regor's CDK inhibitors
Sep 30, 2024 5:30am
